• 18.04.2016

On April 18th, AmCham Healthcare Committee met with the General Director of the Medicines and Medical Devices Agency, Mr. Vladislav Zara, as well as with other representatives of this authority. The discussion focused on the need to amend the procedure for approval and state registration of medicines’ prices. In this regard, AmCham was pleased to receive assurance that multiple recommendations expressed in its position paper will be taken into account by the Agency in drafting the revised version of the Government’s Decision No. 525 from 22.06.2010.